These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3430399)

  • 1. Sulphadimidine acetylation status in Gujarati and Marathi population.
    Kshirsagar NA; Pohujani SM; Takle MR; Acharya VN; Satoskar RS
    J Postgrad Med; 1987 Jul; 33(3):128-33. PubMed ID: 3430399
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulphamethoxazole acetylation in fast and slow acetylators.
    Bozkurt A; Basci NE; Isimer A; Tuncer M; Erdal R; Kayaalp SO
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):164-6. PubMed ID: 2338369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics and drug metabolism: an Irish perspective.
    Holland P; Barry M; Feely J
    Ir J Med Sci; 1991 Feb; 160(2):54-6. PubMed ID: 1917424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
    Singh SP; Pande JN; Khilnani GC; Kailash S
    Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylation phenotyping with sulfamethazine in an Iranian population.
    Sardaş S; Lahijany B; Cok I; Karakaya AE
    Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
    Ylitalo P; Auterinen L; Marttinen A; Koivula T
    Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylation phenotype and skin complexion.
    Rampen FH; van der Meeren HL; Stolk LM
    Acta Derm Venereol; 1986; 66(4):334-6. PubMed ID: 2430405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Acetylation phenotyping with sulfamethazine--problems of sampling.
    Siegmund W; Franke G; Kibittel F; Krüger R
    Pharmazie; 1989 Oct; 44(10):729-30. PubMed ID: 2616620
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of sulphadimidine acetylation test in urine and blood for isoniazid phenotyping.
    Nair CR; Gupta RC; Varshneya AK; Malik SK
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):646-7. PubMed ID: 6526538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of phenazone oxidation and sulfadimidine acetylation in patients with hematologic neoplasms].
    Wiela-Hojeńska A; Milejski P; Orzechowska-Juzwenko K; Usnarska-Zubkiewicz L; Urbaniak-Kujda D; Kotlarek-Haus S
    Przegl Lek; 1997; 54(3):163-6. PubMed ID: 9297191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of isoniazid acetylation phenotypes in North Indians.
    Gupta RC; Nair CR; Jindal SK; Malik SK
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):259-64. PubMed ID: 6746149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation phenotype in colorectal carcinoma.
    Ilett KF; David BM; Detchon P; Castleden WM; Kwa R
    Cancer Res; 1987 Mar; 47(5):1466-9. PubMed ID: 3815349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acetylation phenotype in glomerulonephritis and its clinical significance].
    Milejski P; Orzechowska-Juzwenko K; Strychowski J; Szewczyk Z; Klinger M
    Pol Tyg Lek; 1987 May; 42(18):537-40. PubMed ID: 3628088
    [No Abstract]   [Full Text] [Related]  

  • 14. Undernourished adults and acetylation phenotype.
    Arunkumar Shastri R
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):194-6. PubMed ID: 7076349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of exercise on plasma levels and urinary excretion of sulphadimidine and procainamide.
    Ylitalo P; Hinkka H
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):548-53. PubMed ID: 4066079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report].
    Milejski P; Orzechowska-Juzwenko K; Niewiński P; Hurkacz M; Czarnik-Matusewicz H; Leszek J; Rudzik J; Grotthus B
    Psychiatr Pol; 2007; 41(2):261-9. PubMed ID: 17598435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenotyping in the process of acetylation in man].
    Sitnikova AM; Bulovskaia LN
    Fiziol Cheloveka; 1985; 11(5):856-8. PubMed ID: 4076666
    [No Abstract]   [Full Text] [Related]  

  • 18. N-acetylation phenotype profile in healthy African volunteers using sulphadimidine.
    Adam AM; Ng'anga J; Muthaura C
    East Afr Med J; 1981 Jun; 58(6):401-4. PubMed ID: 7308095
    [No Abstract]   [Full Text] [Related]  

  • 19. [Distribution of acetylator phenotypes in the Moscow population].
    Lil'in ET; Korsunskaia MP; Meksin VA; Tarlycheva LV; Shapiro EF
    Genetika; 1983 Aug; 19(8):1378-80. PubMed ID: 6685091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of acetylator phenotype in Sri Lankans.
    Perera PL; Weerasinghe WM
    Ceylon Med J; 1987 Mar; 32(1):29-34. PubMed ID: 3690726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.